Verve Therapeutics (VERV) Earnings Date, Estimates & Call Transcripts $5.30 +0.02 (+0.28%) As of 10:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Verve Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 14Before Market OpensEstimatedActual EPS (Feb. 27) -$0.58 Beat By $0.14 Consensus EPS (Feb. 27) -$0.72 Verve Therapeutics released Q4 2024 earnings on February 27, 2025, reporting an EPS of -$0.58, which beat analysts' consensus estimates of -$0.72 by $0.14. Quarterly revenue was reported to be $13.08 million, above analyst estimates of $3.94 million. With a trailing EPS of -$2.35, Verve Therapeutics' earnings are expected to decrease next year, from ($2.49) to ($2.83) per share. VERV Upcoming EarningsVerve Therapeutics' next earnings date is estimated for Wednesday, May 14, 2025, based off prior year's reporting schedules. Get Verve Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Verve Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVERV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VERV Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Verve Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.66-$0.60-$0.63Q2 20252-$0.63-$0.63-$0.63Q3 20252-$0.67-$0.65-$0.66Q4 20252-$0.67-$0.66-$0.67FY 20258-$2.63-$2.54-$2.59Q1 20261-$0.77-$0.77-$0.77Q2 20261-$0.74-$0.74-$0.74Q3 20261-$0.75-$0.75-$0.75Q4 20261-$0.77-$0.77-$0.77FY 20264($3.03)($3.03)($3.03) Remove Ads Verve Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/14/2025(Estimated)-------2/27/2025Q4 2024-$0.72-$0.58+$0.14-$0.58$3.94M$13.08M11/5/2024Q3 2024-$0.70-$0.59+$0.11-$0.59$2.75M$6.87M8/8/2024Q2 2024-$0.68-$0.59+$0.09-$0.59$2.40M$6.70M5/8/2024Q1 2024-$0.70-$0.59+$0.11-$0.59$2.11M$5.70M2/27/2024Q4 2023-$0.83-$0.69+$0.14-$0.69$3.95M$5.14M11/7/2023Q3 2023-$0.90-$0.72+$0.18-$0.72$0.96M$3.10M8/10/2023Q2 2023-$0.90-$0.87+$0.03-$0.87$0.67M$2.10M5/15/2023Q1 2023-$0.77-$0.84 -$0.07-$0.84$1.00M$1.40M Verve Therapeutics Earnings - Frequently Asked Questions When is Verve Therapeutics's earnings date? Verve Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 14th, 2025 based off last year's report dates. Learn more on VERV's earnings history. Did Verve Therapeutics beat their earnings estimates last quarter? In the previous quarter, Verve Therapeutics (NASDAQ:VERV) reported ($0.58) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.72) by $0.14. Learn more on analysts' earnings estimate vs. VERV's actual earnings. How much revenue does Verve Therapeutics generate each year? Verve Therapeutics (NASDAQ:VERV) has a recorded annual revenue of $32.33 million. How much profit does Verve Therapeutics generate each year? Verve Therapeutics (NASDAQ:VERV) has a recorded net income of -$200.07 million. VERV has generated -$2.35 earnings per share over the last four quarters. What is Verve Therapeutics's EPS forecast for next year? Verve Therapeutics's earnings are expected to decrease from ($2.49) per share to ($2.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Arcutis Biotherapeutics Earnings Tarsus Pharmaceuticals Earnings Harmony Biosciences Earnings Travere Therapeutics Earnings Janux Therapeutics Earnings Disc Medicine Earnings Agios Pharmaceuticals Earnings Apogee Therapeutics Earnings Vera Therapeutics Earnings Galapagos Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Remove Ads This page (NASDAQ:VERV) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VERV Stock Free VERV Stock Alerts